Expanded Access of Axatilimab to Treat a Single Patient With Chronic Graft Versus Host Disease (GVHD)
NCT05544032 · Status: AVAILABLE · Type: EXPANDED_ACCESS
Last updated 2025-10-08
Summary
This program is being offered on a patient by patient basis and will require company, Institutional Review Board/Independent Ethics Committee and Single Patient IND approval.
Conditions
- Chronic Graft Vs. Host Disease
Interventions
- DRUG
-
axatilimab
Treatment with axatilimab includes receiving intravenous (IV) doses of axatilimab every 2 weeks
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Sex
- Healthy Volunteers
- No
Timeline & Regulatory
More Related Trials
-
A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
NCT04710576 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
NCT06585774 ·Status: RECRUITING ·Phase: PHASE3
-
A Phase 1/2 Study to Evaluate Axatilimab in Participants With Active cGVHD
NCT03604692 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Axatilimab for Sclerotic Chronic Graft-versus-Host Disease
NCT07011810 ·Status: RECRUITING ·Phase: PHASE2
-
Itacitinib for Low Risk GVHD
NCT03846479 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Axatilimab Monotherapy in Japanese Participants With Recurrent or Refractory Active Chronic Graft-Versus-Host Disease
NCT06263478 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256)
NCT07124078 ·Status: RECRUITING ·Phase: PHASE2
-
Study of Itacitinib in Combination With Corticosteroids for the Treatment of Acute GVHD
NCT02614612 ·Status: COMPLETED ·Phase: PHASE1
-
GRAVITAS-301: A Study of Itacitinib or Placebo in Combination With Corticosteroids for Treatment of Acute Graft-Versus-Host Disease
NCT03139604 ·Status: COMPLETED ·Phase: PHASE3
-
Use of Immune Globulin Plus Rituximab for Desensitization in Highly HLA Sensitized Patients Awaiting Deceased Donor Kidney Transplantation
NCT01178216 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
GRAVITAS-119: Itacitinib in Combination With Calcineurin Inhibitor-Based Interventions for the Prophylaxis of Graft-Versus Host Disease
NCT03320642 ·Status: TERMINATED ·Phase: PHASE1
-
A Study of Itacitinib for the Treatment of Chronic Graft Versus Host Disease (cGVHD)
NCT04200365 ·Status: TERMINATED ·Phase: PHASE2
-
Neihulizumab (ALTB-168) in Patients With Steroid-refractory Acute Graft-versus-host Disease or Treatment-refractory Acute Graft-versus-host Disease
NCT03327857 ·Status: COMPLETED ·Phase: PHASE1
-
Itacitinib (INCB039110) and Extracorporeal Photopheresis (ECP) for First-Line Treatment in Chronic GVHD
NCT04446182 ·Status: TERMINATED ·Phase: PHASE2
-
Safety and Clinical Activity of Itolizumab in aGVHD
NCT05823675 ·Status: UNKNOWN ·Phase: PHASE1
-
A Study of Rituximab Combined With Prednisone for the Initial Treatment of Chronic Graft Versus Host Disease (cGVHD)
NCT01066598 ·Status: TERMINATED ·Phase: PHASE2
-
A Study to Evaluate the Safety, Tolerability, PK, PD, and Clinical Activity of EQ001 in Subjects With aGVHD
NCT03763318 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Treatment of Non Severe Hemophagocytosis Lymphohistiocytosis With ITACITINIB
NCT05063110 ·Status: COMPLETED ·Phase: PHASE2
-
Expanded Access for Relatlimab
NCT05170659 ·Status: NO_LONGER_AVAILABLE
-
Effect of Anti-IgE in Chronic Urticaria
NCT00130234 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Gecacitinib in the Treatment of Acute Graft-Versus-Host Disease After Failure of Ruxolitinib-containing Second-line Therapy
NCT07197112 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Gene Therapy for X-CGD
NCT01906541 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
GRAVITAS-309: Itacitinib and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
NCT03584516 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
RATTRAP: Infliximab Versus Rituximab in Systemic Necrotizing Vasculitides
NCT00307593 ·Status: COMPLETED ·Phase: NA
-
A Phase 2 Trial of Rituximab and Corticosteroid Therapy for Newly Diagnosed Chronic Graft Versus Host Disease
NCT00350545 ·Status: COMPLETED ·Phase: NA